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• The agreement between DSM-IV and ICD-10 on opioid dependence was excellent.
• In the clinical samples, the agreement between abuse and harmful use was excellent.
• In the general population, a fair agreement was observed in this regard.
• The inter-rater reliability was perfect or excellent for both systems.⁎ Corresponding author at: Department for Mental He
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IranThe aim of this study was to determine the agreement between the two systems in opioid users in the general
population and a clinical sample. Two series of data were used in this study. The ﬁrst was the data of 236
home-residing opioid abusers aged 15–64, who had previously participated in the Iran Mental Health Survey
(IranMHS) in 2011, and the second was the data of 104 general psychiatry patients from inpatient or outpatient
wards of two psychiatry hospitals in Tehran. Opioid use disorders were evaluated with CIDI-version 2.1.
The disorders were assessed in all participants who used opioid substances for at least 5 times during the past
12 months. In the sample from the general population, the agreement between the two systems on the diagnosis
of dependence was excellent (0.81). The agreement between the two systems on the diagnosis of abuse and
harmful use was 0.41. In the clinical sample, the agreement between the two systems on the diagnosis of depen-
dence or any opioid use disorderwas 0.96 and 0.93, respectively. The agreement between abuse and harmful use
was 0.9 and−0.02with andwithout regarding hierarchy, respectively. The inter-rater reliability of both DSM-IV
and ICD-10 systems for all diagnosis was more than 0.95. The results of the diagnosis of dependence in the two
systems had a weak concordance with treatment. The diagnostic criteria of DSM-IV and ICD-10 regarding
dependence are very similar and the diagnosis produced by each system is concordant with the other system.
However, the two systems have noticeable discrepancies in the diagnosis of abuse and harmful use. The
discrepancies result from their conceptual differences and necessitate further revision in the deﬁnition of these
disorders in the two systems.
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ghts reserved.1. Introduction
Nowadays, two systems are majorly used for the diagnosis of sub-
stance use related disorders. The ﬁrst system is “Diagnostic and Statisti-
calManual ofMental Disorders, 4th Edition (DSM-IV)”, developed by the
American Psychological Association (American Psychiatric Association,
1994). It was published in 1994 and is used in the United States and a
number of other countries. The ﬁrst edition of DSM was developed in
554 M.J. Tarrahi et al. / Addictive Behaviors 39 (2014) 553–5571952. In its third edition published in 1980, substance use related disor-
ders were dissevered from personality disorders.
The second system, International Classiﬁcation of Diseases, has been
developed by theWorld Health Organization and its 10th edition is now
available. It has been used since 1992 in different countries (World
Health Organization, 1993). DSM-IV employs eleven criteria to diagnose
substance use related disorders, 7 for dependence and 4 for abuse.
Thosewhohave at least 3 out of 7 criteria of dependence are categorized
as dependent, and thosewhohave at least 1 out of 4 criteria of abuse are
categorized as abusers.
Similar to DSM-IV, two disorders are deﬁned in the ICD system. The
ﬁrst is dependencewith 6 criteria out ofwhich the existence of at least 3
conﬁrms the diagnosis, and the second is harmful use which includes
conclusive evidence of physical or mental damage caused by substance
use.
Although a lot of criteria are very similar in both systems, one of the
dependence criteria in ICD is the cognitive criterion of craving which is
absent in DSM-IV. In both systems, dependence syndrome is the corner-
stone of substance use related disorders (World Health Organization,
1993, 1994). DSM-IV and ICD-10 are theoretically related (Hasin,
Carpenter, McCloud, Smith, & Grant, 1997; Rounsaville, Bryant, Babor,
Kranzler, & Kadden, 1993) and different studies have evaluated this re-
lationship (Cottler, 1993; Grant, 1993; Hasin, Li, McCloud, & Endicott,
1996; Langenbucher, Morgenstern, Labouvie, & Nathan, 1994a;
Rounsaville et al., 1993). However, this similarity and relationship
reaches its nadir when it comes to abuse and harmful use since the
criteria related to abuse deal with interpersonal, social, occupational,
and legal issues while harmful use puts emphasis on mental or physical
damage caused by substance use.
Different clinical and population-based studies have assessed the
agreement between the two systems. Some studies have evaluated al-
cohol (Grant, 1996; Hasin, Li, McCloud, & Endicott, 1996; Pollock,
Martin, & Langenbucher, 2000; Schuckit et al., 1994), cannabis (Swift,
Hall, & Teesson, 2001), inhalants (Howard, Cottler, Compton, & Ben-
Abdallah, 2001), or alcohol and other substances (Andrews & Slade,
1998; Basu, Gupta, Singh, Mattoo, & Kulhara, 2000; Langenbucher
et al., 1994a; Miele et al., 2001; Rapaport, Tipp, & Schuckit, 1993;
Rounsaville et al., 1993) and assessed the agreement between the
results regarding dependence and abuse (harmful use in ICD) between
DSM-IV and ICD. A number of studies have investigated the reliability of
DSM-IV (Bucholz et al., 1995; Canino et al., 1999; Chatterji et al., 1997;
Easton et al., 1997; Grant, Harford, Dawson, Chou, & Pickering, 1995;
Hasin et al., 1997; Hasin, Hatzenbuehler, Keyes, & Ogburn, 2006; Hasin
et al., 1996; Horton, Compton, & Cottler, 2000; Langenbucher,
Morgenstern, Labouvie, & Nathan, 1994b; Malison et al., 2011; Miele
et al., 2000; Pierucci-Lagha et al., 2007; Ustun et al., 1997) and ICD-10
(Chatterji et al., 1997; Easton et al., 1997; Grant et al., 1995; Hasin
et al., 2006; Miele et al., 2001; Ustun et al., 1997) in the diagnosis of
opioids and other substance related disorders; the results of these
studies are different due to the fact that disorders related to different
substances were assessed and different statistical methods of analysis
were used.
Apart from the knowledge of the reliability of the methods of diag-
nosing opioid related disorders, what makes this study necessary is
that ﬁrst, DSM-IV and ICD are nowadays considered important tools of
collecting data and presenting health related statistics in national and
international levels and therefore, it is necessary to know the agreement
between the two systems in order to compare the calculated indices
between them. Second, it is important to know the agreement between
the two systems to evaluate the success of the efforts to integrate the
criteria of the two systems andmake themevenmore similar or to devel-
op a single system. Third and most important of all, knowledge of the
similarities and differences, and efforts to lower the differences can
make future studies on substance use disorders more homogenous and
therefore will result in scientiﬁc advances regarding these disorders
(Grant, 1996).Since a limited number of studies have evaluate the agreement be-
tween ICD-10 and DSM-IV in the users of opioid substances worldwide
and considering the fact that Iran holds oneof the highest rates of opioid
use in the world (United Nations Ofﬁce on Drugs and Crime, 2011), we
used the data of the Iran Mental Health Survey (IranMHS) to assess the
agreement between the two systems in opioid users in the general pop-
ulation. Moreover, the data of another study on psychiatric patients
were also used and similar analyses were performed.
2. Methods
2.1. Data
Two series of data were used in this study. The ﬁrst series was the
data of the Iran Mental Health Survey (IranMHS), a cross-sectional
household study with sampling performed in the national level. The
study population of IranMHS was home-residing Iranian people aged
15–64 out of whom 7886 individuals were selected through 3-stage
random sampling. The complete methodology of this survey has been
already published (Rahimi-Movaghar et al., in print). The main tool for
data collection and analysis in this study was Composite International
Diagnosis Interview version 2.1 (CIDI 2.1), 12-Month version. The
reliability of the Persian version of modules of drugs and alcohol in
psychiatric inpatients and outpatients has been already evaluated and
conﬁrmed (Arabgol et al., 2005). These modules contain questions on
screening, frequency of use, and the symptoms of substance use disor-
ders including abuse and dependence, designed based on both ICD-10
and DSM-IV criteria. Out of 7886 participants of this study, 236 had a
history of using opioids for at least 5 times in the past 12 months and
all the criteria of opioid use disorders based on ICD-10 and DSM-IV
were investigated in all 236 users.
The second series was the data of a clinical study performed in two
university-afﬁliated psychiatry hospitals, Iran and Rouzbeh. In this
study, 104 adult inpatients or outpatients with general psychiatric
disorders were included through purposeful sampling based on the
inclusion and exclusion criteria under the supervision of two team
member psychiatrists. CIDI-version 2.1—12 Month was also employed
in this study, as well. There was one interviewer and one observer
who ﬁlled the questionnaires independently. The observer was allowed
to ask more questions if necessary. They were clinical psychologists
with work experience in psychiatric hospitals and were trained for
this ﬁeld work.
CIDI-version2.1-12Month includes thediagnostic criteria of DSM-IV
and ICD-10. According to DSM-IV, the criteria of dependence are toler-
ance; withdraw; taking the substance in larger amount and for longer
periods than before; persistent desire or repeated unsuccessful
attempts to decrease or control substance use; spending much time/
activity to obtain, use, or recover; giving up or reducing important social
activities for substance use; and continueduse despite knowledge of ad-
verse continuous or recurrent psychological and physical consequences
likely to have been caused or exacerbated by substance. The criteria for
abuse in DSM-IV include failure to fulﬁll major role obligation at work,
home or school; use in hazardous situations; recurrent substance
related legal problems; and continued use despite persistent or recur-
rent social or interpersonal problems (American Psychiatric Association,
1994). The criteria of dependence according to ICD-10 are a strong
desire or sense of compulsion to take the substance; difﬁculties in con-
trolling substance-taking behavior in terms of its onset, termination, or
levels of use; withdrawal symptoms; tolerance; preoccupation with
substance use, as manifested by important alternative pleasures or in-
terests being given up or reduced because of substance use; or a great
deal of time being spent in activities necessary to obtain, take or recover
from the effects of the substance despite clear evidence. To diagnose
harmful use according to ICD-10, there must be clear evidence that
the substance use is responsible for (or substantially contributed to)
physical or psychological harm, including impaired judgment or
Table 2
Comparison of treatment history in the past 12 months with diagnosis based on DSM-IV
and ICD-10(IranMHS, n = 236).
Treatment in L12M No treatment Outpatient care Inpatient care Total
DSM-IV Negative 89 (89) 11(11) 0 (0) 100 (100)
Abuse 17 (85) 2 (10) 1 (5) 20 (100)
Dependence 43(37.1) 52(44.8) 21 (18.1) 116 (100)
555M.J. Tarrahi et al. / Addictive Behaviors 39 (2014) 553–557dysfunctional behavior, which may lead to disability or have adverse
consequences for interpersonal relationships. The nature of the harm
should be clearly identiﬁable and speciﬁed. The pattern of use must
have persisted for at least 1 month or has occurred repeatedly within
a 12-month period. The disorder should not meet the criteria for any
other mental or behavioral disorder related to the same drug in the
same time period (World Health Organization, 1993).Total 149 (63.1) 65 (27.5) 22 (9.3) 236 (100)
ICD-10 Negative 93 (84.5) 15 (13.6) 2 (1.8) 110 (100)
Harmful use 5 (83.3) 1 (16.7) 0 (0) 6 (100)
Dependence 51 (42.5) 49 (40.8) 20 (16.7) 120 (100)
Total 149 (63.1) 65 (27.5) 22 (9.3) 236 (100)2.2. Statistical analysis
Kappa was used to assess the agreement between DSM-IV and ICD-
10 (Cohen, 1960). Yule's Y statistic (Yule, 1912) was used since the
prevalence of abuse and harmful use was low. Similar to Kappa, Yule's
Y statistic has a range of−1 to +1 where +1 indicates perfect agree-
ment, 0.75 shows excellent agreement, 0.4 to 0.74 suggests fair to
good agreement, and less than 0.39 represents poor agreement. Kappa
takes on the value zero if there is no more agreement between two
judges or tests as can be expected on the basis of chance (Fleiss,
1981). The Kendall Tau coefﬁcientwas used to assess the agreement be-
tween the DSM-IV and ICD-10 on the results of diagnosis and treatment
status.Table 3
Agreement on diagnosis between DSM-IV and ICD-10 in the clinical samples.3. Results
In the sample obtained from the general population, the prevalence
of the opioid dependence, opioid abuse, and any opioid use disorder
based on DSM-IV was 0.49%, 0.08%, and 0.58%, respectively.
According to ICD-10, the prevalence of dependence, harmful use,
and any opioid use disorder was 0.51%, 0.025%, and 0.53%, respectively.
Regardless of dependence, having the criteria of abuse without consid-
ering hierarchy was 0.48% based on DSM-IV and having the criteria of
harmful use was 0.35% according to ICD-10.
The agreement between the two systems on the diagnosis of depen-
dencewas excellent (0.81) but their agreement on the diagnosis of abuse
and harmful use was poor based on Kappa (0.12). However, since the
aforementioned rates were low, Yule's Y statistic was calculated which
showed a fair agreement (0.41). The agreement between the two
systems on any diagnosis was 0.73, which was good. The agreementTable 1
The indices of agreement between DSM-IV and ICD-10 (IranMHS, n = 236).
ICD-10 Kappa
DSM-IV Dependence No dependence Total 0.81(0.74–0.89)
Dependence 107 9 116
No dependence 13 107 120
Total 120 116 236
DSM-IV Any diagnosis No diagnosis Total 0.73(0.64–0.81)
Any diagnosis 115 21 136
No diagnosis 11 89 100
Total 126 110 236
DSM-IV Diagnosis of
harmful use
No diagnosis
of harmful use
Total 0.41(0.05–0.78)⁎
Abuse 2 18 20
No abuse
diagnosis
4 212 216
Total 6 230 236
DSM-IV With
symptoms of
harmful use
Without
symptoms of
harmful use
Total 0.52(0.41–0.62)
With
symptoms
of Abuse
69 43 112
Without
symptoms
of abuse
13 111 124
Total 82 154 236
⁎ Yule's Y statistic was used since the prevalence of abuse and harmful use was low.between the two systems on the diagnosis of abuse and harmful use,
regardless of hierarchy, was almost good (0.52) (Table 1).
Table 2 presents the results of the comparison of treatment history
for opioid use disorders with diagnosis made based on ICD-10 and
DSM-IV in the general population. The calculated Kappa and Kendall co-
efﬁcient for treatment status and results were 0.21 and 0.49 for DSM-IV
and 0.21 and 0.42 for ICD-10, respectively.
In a study on 104 clinical samples, the two systems showed an excel-
lent agreement on the diagnosis of dependence, but the agreement for
abuse and harmful use was poor (Table 3). The inter-rater reliability
for both DSM-IV and ICD-10 was excellent (Table 4).
4. Discussion
The results of the current study showed that the agreement between
the two systems on the diagnosis of dependence in opioid users was
excellent in both the general population and the clinical samples. In
the clinical samples, the agreement between abuse and harmful use
was excellent but in the general population, a fair agreement was
observed in this regard.
To our best knowledge, this is the ﬁrst study of the agreement
between DSM-IV and ICD-10 on opioid use disorders in the generalICD-10 Kappa
DSM-IV Dependence No
dependence
Total 0.95(0.91–0.99)
Dependence 32 1 33
No
dependence
1 70 71
Total 33 71 104
DSM-IV Any diagnosis No diagnosis Total 0.91(0.83–0.99)
Any
diagnosis
67 1 68
No
diagnosis
3 33 36
Total 70 34 104
DSM-IV Diagnosis
of harmful
use
No diagnosis
of harmful
use
Total −0.02
(−0.04–0.007)
Abuse 0 3 3
No abuse
diagnosis
1 100 101
Total 1 103 104
DSM-IV With
symptoms
of harmful
use
Without
symptoms of
harmful use
Total 0.89(0.79–0.99)
With
symptoms
of abuse
25 2 27
Without
symptoms
of abuse
2 61 63
Total 27 63 90
Table 4
Inter-rater reliability of diagnosis in the clinical sample based on DSM-IV and ICD-10.
Interviewer Kappa
DSM-IV Observer Dependence No dependence Total 0.97(0.94–1)
Dependence 33 1 34
No dependence 0 70 70
Total 33 71 104
Observer Abuse No abuse Total 0.96(0.93–0.99)
Abuse 34 2 36
No abuse 0 68 68
Total 34 70 104
ICD-10 Observer Dependence No dependence Total 0.95(0.91–0.99)
Dependence 32 1 33
No dependence 1 70 71
Total 33 71 104
Observer Harmful use No harmful use Total 1
Harmful use 26 0 26
No harmful use 0 63 63
Total 26 63 89
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ples reported an excellent agreement between the two systems on the
diagnosis of dependence (Langenbucher et al., 1994a; Schuckit et al.,
1994). Two other studies (Basu et al., 2000; Miele et al., 2001) reported
a good agreement, whichwas lower than the agreement in our study. In
regards to the agreement between the two systems on the diagnosis of
alcohol dependence, an excellent agreement has been reported by a
number of studies which is in line with our results (Grant, 1996;
Langenbucher et al., 1994a; Miele et al., 2001; Rapaport et al., 1993).
These results were expected since the diagnostic criteria of dependence
are similar in DSM-IV and ICD-10. However, DSM-V new deﬁnition
of substance use disorder, which combines the criteria of substance
dependence and substance abuse with some changes and present
a one-dimensional concept, might show a higher difference with
ICD-10.
The results of the agreement on harmful use and abuse in the gener-
al population and the clinical samples were not satisfactory; the agree-
mentwas fair in the sample from the general population and poor in the
clinical sample.Many studies that have evaluated the agreement in clin-
ical samples have reported different results. Langenbucher reported a
good agreement in alcohol users and an excellent agreement in opioid
users (Langenbucher et al., 1994a) while Shuckit et al. showed a poor
agreement in all types of substance users, including opioid users
(Schuckit et al., 1994). Furthermore, some studies have reported a fair
agreement in substance users (Miele et al., 2001; Rapaport et al.,
1993). In different samples of the general population, the agreement
between harmful use and abuse in the users of alcohol, cocaine, and
cannabis has been reported to be poor to fair (Andrews & Slade, 1998;
Grant, 1996; Hasin, Li, McCloud, & Endicott, 1996; Swift et al., 2001),
which is almost similar to the results of the current study. These two
diagnostic systems have conceptual differences in the diagnosis of
harmful use and abuse. Abuse highlights social, occupational, legal and
physical problems while harmful use puts emphasis only on psycholog-
ical or physical damage, which make their agreement noticeably lower
that the agreement on the criteria of dependence. In addition, this
study showed that harmful use, which is somehow different concept
than abuse is uncommon in opioid users.
In the current study, the inter-rater reliability was perfect or excel-
lent for both systems. Similar to our study, studies that evaluated the re-
liability of DSM-IV in the diagnosis of substance use related disorders
showed that the reliability was excellent (Chatterji et al., 1997; Easton
et al., 1997; Hasin, Trautman, et al., 1996; Langenbucher et al., 1994b;
Malison et al., 2011; Miele et al., 2001) or good (Hasin et al., 2006;
Horton et al., 2000; Ustun et al., 1997), for opioids; a good to excellent
reliability has also been reported for alcohol (Canino et al., 1999;
Chatterji et al., 1997; Easton et al., 1997; Grant et al., 1995; Hasin
et al., 1997; Hasin et al., 2006; Hasin, Li, McCloud, & Endicott, 1996;Hasin, Trautman, et al., 1996; Horton et al., 2000; Miele et al., 2000) or
other substances like cocaine, cannabis, stimulants, and sedatives
(Bucholz et al., 1995; Chatterji et al., 1997; Easton et al., 1997; Grant
et al., 1995; Hasin et al., 1997; Hasin et al., 2006; Hasin, Trautman,
et al., 1996; Horton et al., 2000; Langenbucher et al., 1994b; Miele
et al., 2000; Pierucci-Lagha et al., 2007).
The reliability of ICD-10 in the diagnosis of heroin related disorders
(Grant et al., 1995;Miele et al., 2001), cocaine, cannabis, sedatives, stim-
ulants, and hallucinogens (Chatterji et al., 1997; Easton et al., 1997;
Grant et al., 1995; Hasin et al., 2006; Miele et al., 2001; Ustun et al.,
1997) has been reported good to excellent; however, the current
study showed a higher reliability in comparison with them.
Comparison of the results of diagnosing a disorder with ICD-10 and
DSM-IV with history of receiving treatment showed that in contrary
to our expectations, not all of those who sought treatment in the past
12 months had the diagnosis of opioid use disorders in the same time
period, which is conﬁrmed by the weak Kappa and Kendall coefﬁcient.
However, it should be noted that self-reports on clinical symptoms
may not be 100% accurate and opioid use disorders may have been
underreported.
It should be noted that consuming, carrying, buying, and selling opi-
oids is a criminal offense in Iran; although several measures were taken
in the IranMHS survey and the clinical survey to ensure participants
about conﬁdentiality, it is very likely that this limitation led to an
underestimated number of substance users and affected the declared
pattern of symptoms.
The present study had two strong points; ﬁrst, a representative
sample of the general population was used, which enhanced the exter-
nal validity of the study and second, clinical samples from two referral
centers in Tehran were also used and the agreement between the two
groups was evaluated simultaneously.
5. Conclusion
The agreement between ICD-10 and DSM-IV on the diagnosis of de-
pendence was excellent in both the general population and the clinical
sample and it shows that for both clinical and research purposes using
DSM-IV or ICD-10 classiﬁcation does not differ considerably for opioid
dependence. However, in regards to abuse andharmful use, an excellent
agreement was only noted in the clinical sample and the agreement in
the general population was poor, indicating that the diagnostic criteria
of DSM-IV and ICD-10 regarding dependence are very similar and the
diagnoses produced by each system is concordant with the other
system. Nevertheless, the two systems have noticeable discrepancies
in the diagnosis of abuse and harmful use. The discrepancies result
from their conceptual differences and necessitate further revision in
the deﬁnition of these disorders in the two systems.
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